Phil Jeynes, Pru Health, spoke to Financial Reporter at the recent FSE London show about the effects of the Gender Directive and RDR on protection sales, the problems with simplified critical illness products, and tackling the mortality protection gap in the UK.
Phil Jeynes, Pru Health, spoke to Financial Reporter at the recent FSE London show about the effects of the Gender Directive and RDR on protection sales, the problems with simplified critical illness products, and tackling the mortality protection gap in the UK.
